Actively Recruiting

All Genders
NCT05630105

Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene

Led by Institut Bergonié · Updated on 2025-12-02

430

Participants Needed

1

Research Sites

1281 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multicentric, observational, retrospective and prospective study, aiming to estimate the risk of cancer occurrence in subjects carrying a PTEN mutation, based on the constitution of a national cohort.

CONDITIONS

Official Title

Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female
  • Any age, adult or child
  • Carrier of a constitutional or mosaic alteration of the PTEN gene confirmed by Institut Bergoni�e9's genetics laboratory
  • Informed of genetic diagnosis
  • Informed and not opposed to participation
  • Affiliated with French social security as required by French research law
Not Eligible

You will not qualify if you...

  • Under guardianship or curatorship, except participants with autism
  • Deprived of liberty by judicial or administrative decision
  • Under psychiatric care or admitted to health or social establishment for non-research reasons, except participants with autism

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut Bergonié, Comprehensive Cancer Center

Bordeaux, France

Actively Recruiting

Loading map...

Research Team

V

Virginie BUBIEN, Dr

CONTACT

S

Simone MATHOULIN-PELISSIER, Pr

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here